0141 352 98 55

25 Blythswood Square, Glasgow, G2 4BL

Tracking Covid vaccine progress through Medsmart®
March 3, 2021

In the race against new super spreading virus variants, the UK among other countries have implemented a fast streamed vaccine programme to protect the vulnerable as quickly as possible. Since the beginning of January, 17,916,181 people in the UK have been given their first dose of a COVID-19 vaccine, accounting for around 26% of the population.2,3

As a company with close interaction to patients, we know more than anyone the burden and effect COVID-19 is having on patient populations. Over the course of the pandemic, Talking Medicines have been doing all we can to support our Medsmart® community while sharing data insight that we hope will positively influence patient experience going forwards.

With mass immunisation moving so quickly we were interested in seeing how the results of some of our Medsmart® App features lined up with these government figures.

COVID-19 Tracker

In May 2020 we added the COVID-19 tracker into Medsmart®. This feature was added to allow patients to document their COVID status – whether they suspect that they have COVID, they have had their diagnosis confirmed by a test or are indeed uninfected.

Over the course of the last few months, we have seen steady use of this feature by our Medsmart® community, with an increased number of users confirming their COVID status every week.

COVID-19 Vaccine tracker

At the end of last year, we added an additional feature – our COVID-19 vaccine tracker. This has a similar principle to the COVID-19 tracker, however this version records whether or not Medsmart® users have been vaccinated.

The majority of those using our feature were in the age group of 60-75 years old, with 62% of total participants being male.

We have also been looking at what health conditions users of this feature have. From this analysis we see that the most common conditions are acid reflux, depression, anxiety, high blood pressure and high cholesterol.

Unsurprisingly, many of the medicines being taken match to the common health conditions. We are seeing a high use of Atorvastatin (High cholesterol medicine), Mirtazapine (Depression medicine) and Allopurinol (Gout and Kidney stone medicine).

We believe that the data we collect about coronavirus, patients and vaccines can be used for good. It is important to us that we use our tools not only to connect patients with the wider healthcare system but also to connect the healthcare system back to the patients and their voices. We hope that by continuing to collate and structure data from our COVID-19 trackers, we can continue to contribute to the COVID-19 effort as we continue to strive for a route back to normality.


  1. Man using analytics software on his mac (https://unsplash.com/photos/pypeCEaJeZY)
  2. https://www.bbc.com/news/health-55274833
  3. https://coronavirus.data.gov.uk/details/vaccinations

Recent Blogs

Appointment of Head of Data Quality

Appointment of Head of Data Quality

Data insights firm Talking Medicines, specialist in ‘social intelligence’ for the pharmaceutical industry, has appointed Donna Lawson to the position of Head of Data Quality. A particularly good fit for the role, Donna brings with her over two decades’ experience...

The effect of self-diagnosis on patient outcomes

The effect of self-diagnosis on patient outcomes

The internet is a wonderful place. You can find photos of places you want to visit, maps of your favourite mountain ranges, tutorials on how to bake the perfect birthday cake…the list goes on. In recent years, however, there has been a marked increase in the number of...

Pharma Business International Interview

Pharma Business International Interview

Pharma Business International spoke with Jo Halliday, CEO of Talking Medicines, the world’s first social intelligence company designed specifically for the pharmaceutical industry.  The full article can be found here on page 10-11 Tell us about Talking Medicines?...